Avg target $9.33+14.9%Median $9.00High $12.00Low $7.003 targets in the last 12 months
Price vs average target
Revenue and EPS estimates
Reported
Consensus estimates
Fiscal period
FY2023Dec '23
FY2024Dec '24
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
FY2029Dec '29
FY2030Dec '30
Revenue (B)
0.92
0.99
1.18
1.24
1.32
1.42
1.60
1.72
Growth YoY
−3.8%
+7.6%
+19.0%
+4.5%
+6.5%
+7.6%
+12.7%
+7.9%
High estimate
–
–
–
1.25
1.34
1.48
1.63
1.76
Low estimate
–
–
–
1.22
1.31
1.37
1.57
1.70
Analysts
–
–
–
6
6
6
4
3
EPS, adjusted
1.31
1.29
1.63
1.33
1.48
1.60
2.29
2.60
Growth YoY
−6.4%
−1.5%
+26.4%
−18.6%
+11.7%
+8.2%
+42.8%
+13.5%
High estimate
–
–
–
1.38
1.62
1.89
2.35
2.67
Low estimate
–
–
–
1.24
1.37
1.44
2.24
2.55
Analysts
–
–
–
6
6
4
1
1
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
5 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Morgan Stanley
James Faucette
Equal Weight
Equal Weight
$7.00
$6.00
+17%
−14%
Aug 11
Robert W. Baird
–
Outperform · Oct 2025
Neutral
$12.00
$18.00
−33%
+48%
Aug 6
Wedbush
Michael Piccolo
Outperform
Outperform
$9.00
$15.00
−40%
+11%
Aug 6
Goldman Sachs
–
Sell
Sell
–
–
–
–
May 7
RBC Capital
–
Sector Perform
Sector Perform
–
–
–
–
Feb 26
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data